Two cases of gastrointestinal bleeding in patients being treated with continuous-release aminophylline tablets are reported.
Introduction
Theophylline and its derivatives are given orally to relieve the dyspnoea of obstructive airways disease and left ventricular failure. Their use has been limited by nausea and vomiting, side effects thought to be related to high concentrations of theophylline in plasma (Jenne et al., 1972) and not to local gastrointestinal irritation. Oral formulations which will produce plasma theophylline levels reliably within the therapeutic range have therefore been sought. The authors treated a series of inpatients, expected to benefit from a theophylline derivative, with a continuous-release aminophylline tablet (Boroda et al., 1973) . Gastrointestinal (Pearson, 1964; Meyler, 1966; Meyler and Herxheimer, 1968) strengthen the possibility of a causal relationship. It may be relevant that high doses of caffeine, which is also a methylated xanthine, increase gastric acid output and cause duodenal ulceration in some animal species (Goodman and Gilman, 1975) .
In one large study (Jenne et al., 1972) gastrointestinal side effects of aminophylline occurred only with plasma theophylline concentrations higher than 13 ,ug/ml, and generally with concentrations above 20 jig/ml. In the first case described in this paper the plasma theophylline concentration (50 jig/ml) was clearly in the toxic range. In the second patient the trough plasma concentration was 91 ,ug/ml, and with this formulation (Boroda et al., 1973) it seems unlikely that the peak concentration exceeded 13 ,ug/ml. If aminophylline did cause the oesophagitis in this patient, this suggests either that it had a local irritative action, or that systemic toxic effects may occur occasionally with plasma theophylline concentrations below 13 jig/ml. The first case history illustrates the advisability of monitoring plasma theophylline levels when prescribing theophylline derivatives. Nausea and vomiting while taking aminophylline 450 mg daily were so transient that they were not recognized as symptoms of possible toxicity. The patient was otherwise entirely asymptomatic despite a dangerously high plasma theophylline concentration until the haematemesis supervened. The reason for the very high plasma level in this case is not known but a very long theophylline half-life (28 hr) in a 71-year-old man without liver dysfunction has been reported previously (Jacobs and Senior, 1974) . This indicates the need for caution in adjusting oral aminophylline dosage in the elderly, particularly where there is concurrent physical illness, and suggests the need for further study of theophylline kinetics in the elderly. aminophylline treatment. 
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